MetLife Q2 adjusted profit beats estimates on favorable underwriting, broad-based volume growth
MetLife Q2 adjusted profit beats estimates on favorable underwriting, broad-based volume growth
Overview
US insurance and employee benefits provider's Q2 revenue rose compared to last year
Adjusted EPS for Q2 rose 20% and beat analyst expectations
Company returned over $1.1 bln to shareholders via share repurchases and dividends
Outlook
Company did not provide specific guidance for the current or future periods
Result Drivers
UNDERWRITING & VOLUME GROWTH - Co said adjusted earnings growth was driven by favorable underwriting and broad-based volume growth across all segments
NET INVESTMENT INCOME - Net investment income rose 18%, primarily due to increases in estimated fair value of certain securities that do not qualify as separate accounts under GAAP
SEGMENT PERFORMANCE - Group Benefits, Asia, and Latin America segments saw notable adjusted earnings growth, attributed to favorable underwriting, volume growth, and market factors
Company press release: ID:nBw38dFCha
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $19.15 bln | $19.71 bln (7 Analysts) |
Q2 Adjusted EPS | Beat | $2.43 | $2.29 (15 Analysts) |
Q2 EPS |
| $1.09 |
|
Q2 Adjusted Net Income |
| $1.57 bln |
|
Q2 Net Income |
| $705 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for MetLife, Inc. is $98.50, about 2.5% above its August 4 closing price of $96.13
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago
Reuters Recommended Reads
Aug 4 - Prudential Q2 profit rises 85% on higher asset management fees
Aug 4 - Equitable Holdings Q2 adjusted EPS beats estimates as AUM rises
Aug 3 - Jackson Financial Q2 profit jumps on favorable hedging, annuity sales growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on MetLife
See all newsMedia: Prudential Mexico, Brazil units draw interest from MetLife, CNP - Bloomberg News
US RESEARCH ROUNDUP-Danaher Corporation, Illumina, Reliance
Brief: Metlife Full-Year 2026 Guidance For Variable Investment Income About $1.60 Billion Pre-Tax
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
MetLife, Inc. reports results for the quarter ended June 30 - Earnings Summary